Role of ADP-ribosylation in Stress Granules

ADP-核糖基化在应激颗粒中的作用

基本信息

  • 批准号:
    10703465
  • 负责人:
  • 金额:
    $ 40.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-03-01 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary Membrane-less structures are prevalent in cells and executing unique functions (e.g., DNA repair foci and nucleoli for making ribosomal subunits). The mechanisms by which their formation, size, number, and dynamics are regulated, however, remain unclear. Emergent studies revealed that their formation can be partly explained by a biophysical phenomenon known as liquid-liquid phase separation, whereby the nucleoplasm and cytoplasm are considered complex fluids that stably segregate like oil and water. Phase separation is often triggered when proteins bind to a common scaffold such as the nucleic acids DNA and RNA, resulting in the condensation of proteins to form higher-order structures. We previously discovered that an under-studied nucleic acid called poly(ADP-ribose) (PAR) is critical for the formation of a class of membrane-less organelles implicated in cancer, virus infection and neurodegeneration called stress granules. Stress granules are cytoplasmic RNA-protein assemblies formed in different sizes in response to stressors such as hypoxia, oxidative stress and heat shock. Most granule components dynamically exchange with the surrounding cytoplasm, and individual granules grow in size over time through fusion. Notably, stress granules in models of neuropathological diseases, such as amyotrophic lateral sclerosis (ALS), have slower exchange dynamics and are less able to fuse. However, the molecular factors that control the stress granule dynamics and fusion (which affects size and number of granules) remain poorly understood. In this proposal, we will (1) determine how PAR regulates phase separation in stress granules using innovative techniques to define critical parameters of ADP- ribosylation for stress granule formation in cells and in vitro, and (2) determine whether PAR- protein interactions regulate stress granule fusion using mutagenesis, live-cell imaging, biophysical methods and proteomics. Projected Impact: Besides its role in stress granules, PAR is also critical for the formation of time- and location-specific membrane-less structures, including DNA repair complexes and nucleoli. This proposal will thus advance the field by defining critical parameters for physiologically relevant PAR-mediated phase separation and by identifying ADP-ribosylated proteins required for these phenomena. Given that PARPs are druggable and actively targeted by pharmaceutical companies, next-generation inhibitors may be designed to modulate the formation and dynamics of physiological and pathological membrane-less structures in neurological or other diseases.
项目摘要 无膜结构在细胞中普遍存在,并执行独特的功能(例如,DNA 修复灶和用于制造核糖体亚基的核仁)。它们的机制 然而,其形成、大小、数量和动力学是否受到调控仍不清楚。紧急 研究表明,它们的形成可以部分地用生物物理现象来解释, 称为液-液相分离,由此核质和细胞质被分离。 被认为是像油和水一样稳定分离的复杂流体。相分离通常 当蛋白质结合到共同的支架如核酸DNA和RNA时触发, 导致蛋白质缩合形成高级结构。我们之前 发现一种研究不足的核酸称为聚(ADP-核糖)(PAR)是关键的 形成一类与癌症、病毒感染和 称为应激颗粒的神经变性。应激颗粒是细胞质RNA蛋白 反应于应激源如缺氧、氧化应激 和热休克。大多数颗粒成分与周围环境动态交换 细胞质,并且单个颗粒通过融合随着时间的推移而在尺寸上生长。值得注意的是, 在神经病理学疾病,如肌萎缩侧索硬化症(ALS), 交换动力较慢,融合能力较弱。然而,分子因素, 控制应力颗粒动力学和融合(影响颗粒的大小和数量) 人们对它了解仍然很少。在这个建议中,我们将(1)确定PAR如何调节相位 使用创新技术分离应力颗粒,以确定ADP的关键参数, 核糖基化用于细胞和体外应激颗粒形成,和(2)确定PAR- 蛋白质相互作用利用诱变,活细胞成像, 生物物理方法和蛋白质组学。预计的影响:除了在应激颗粒中的作用,PAR 也是形成时间和位置特异性无膜结构的关键, 包括DNA修复复合物和核仁。因此,该提案将通过以下方式推动该领域的发展: 定义生理学相关PAR介导的相分离的关键参数, 鉴定这些现象所需的ADP核糖基化蛋白。鉴于PARP是 下一代抑制剂可用于药物治疗,并被制药公司积极瞄准, 设计用于调节生理和病理的 神经系统或其他疾病中的无膜结构。

项目成果

期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Preparation of Recombinant Alphaviruses for Functional Studies of ADP-Ribosylation.
用于 ADP-核糖基化功能研究的重组甲病毒的制备。
  • DOI:
    10.1007/978-1-4939-8588-3_21
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Abraham,Rachy;McPherson,RobertLyle;Sreekumar,Easwaran;Leung,AnthonyKL;Griffin,DianeE
  • 通讯作者:
    Griffin,DianeE
Poly(ADP-ribose)-dependent ubiquitination and its clinical implications.
  • DOI:
    10.1016/j.bcp.2019.05.006
  • 发表时间:
    2019-05
  • 期刊:
  • 影响因子:
    5.8
  • 作者:
    Christina A. Vivelo;V. Ayyappan;A. Leung
  • 通讯作者:
    Christina A. Vivelo;V. Ayyappan;A. Leung
ADPr-ChAP: Mapping ADP-Ribosylation onto the Genome.
ADPr-ChAP:将 ADP-核糖基化映射到基因组上。
  • DOI:
    10.1016/j.molcel.2016.01.023
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    16
  • 作者:
    McPherson,RobertLyle;Leung,AnthonyKL
  • 通讯作者:
    Leung,AnthonyKL
The Whereabouts of microRNA Actions: Cytoplasm and Beyond.
  • DOI:
    10.1016/j.tcb.2015.07.005
  • 发表时间:
    2015-10
  • 期刊:
  • 影响因子:
    19
  • 作者:
    Leung AKL
  • 通讯作者:
    Leung AKL
RNA Granules and Diseases: A Case Study of Stress Granules in ALS and FTLD.
RNA颗粒和疾病:ALS和FTLD中应力颗粒的案例研究。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anthony K L Leung其他文献

Anthony K L Leung的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anthony K L Leung', 18)}}的其他基金

Defining the Role of Poly ADP-ribose in Biomolecular Condensation in ALS and FTLD
定义聚 ADP-核糖在 ALS 和 FTLD 生物分子缩合中的作用
  • 批准号:
    10157522
  • 财政年份:
    2020
  • 资助金额:
    $ 40.17万
  • 项目类别:
Role of ADP-ribosylation in Stress Granules
ADP-核糖基化在应激颗粒中的作用
  • 批准号:
    10388732
  • 财政年份:
    2015
  • 资助金额:
    $ 40.17万
  • 项目类别:
Post-transcriptional Gene Regulation by Cytoplasmic Poly(ADP-ribose) Polymerases
细胞质聚(ADP-核糖)聚合酶的转录后基因调控
  • 批准号:
    9234547
  • 财政年份:
    2015
  • 资助金额:
    $ 40.17万
  • 项目类别:
Post-transcriptional Gene Regulation by Cytoplasmic Poly(ADP-ribose) Polymerases
细胞质聚(ADP-核糖)聚合酶的转录后基因调控
  • 批准号:
    8886016
  • 财政年份:
    2015
  • 资助金额:
    $ 40.17万
  • 项目类别:
Role of ADP-Ribosylation in Stress Granules-Equipment Supplement
ADP-核糖基化在应激颗粒-设备补充剂中的作用
  • 批准号:
    10683638
  • 财政年份:
    2015
  • 资助金额:
    $ 40.17万
  • 项目类别:
Role of ADP-ribosylation in Stress Granules
ADP-核糖基化在应激颗粒中的作用
  • 批准号:
    10268197
  • 财政年份:
    2015
  • 资助金额:
    $ 40.17万
  • 项目类别:
Role of ADP-ribosylation in Stress Granules
ADP-核糖基化在应激颗粒中的作用
  • 批准号:
    9973639
  • 财政年份:
    2015
  • 资助金额:
    $ 40.17万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 40.17万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 40.17万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.17万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.17万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 40.17万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.17万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 40.17万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 40.17万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 40.17万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.17万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了